The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Block

• Status: Not yet recruiting
• Trial end date: 2026-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Peripheral nerve blocks are essential in ensuring effective regional anesthesia and postoperative analgesia in forefoot surgery for hallux valgus repair. Many factors influence the onset and duration of peripheral nerve blocks. In the advent of ultrasound-guided nerve blocks, the accuracy in administering LA has significantly improved, potentially reducing the required dosage, which is also associated with less risk for toxicity. However, the effect of the concentration of LA on the onset time and duration of ultrasound-guided ankle blocks for forefoot surgery has not yet been studied. This poses a clinically relevant dilemma regarding the necessity of administering lower or higher concentrations of ropivacaine to achieve a clinically relevant faster onset time and longer duration of an ankle block.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ziekenhuis Oost-Limburg
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Provide signed and dated informed consent

• Age 18 to 65 years, scheduled for elective forefoot surgery for hallux valgus repair under unilateral ankle block at ZOL Genk

• ASA physical I-II-III

• Able to understand the researchers

• Able to ambulate (ability to walk independently, with or without assistive devices)

• Able to learn and perform study sensory and motor assessment by exhibiting sensitivity to pinprick, cold, and light touch (tested beforehand with pinprick/cold/ light touch sensation test) as the patient will have to perform these sensory and motor assessments by him/herself at home at postoperative day 0 to 2

Exclusion Criteria:

• Language barrier

• Preexisting lower extremity neuropathy

• Contraindications to ankle block (local infection, edema, burn, soft tissue trauma, or distorted anatomy with scarring in the area of block placement)

• Contraindications for use of NSAIDs

• Allergy to local anesthetics

• Uncontrolled anxiety, psychiatric or neurological disorder that might interfere with study assessment

• Weight below 50 kg based on a maximum dose of 3 mg/kg ropivacaine and a maximum dose of 150 mg ropivacaine.

• Preoperative use of opioids or gabapentin less than 3 days before surgery